Deborah H. Yellin

Hatch-Waxman PTE For Reissue Patents Should Be Calculated From The Original Patent's Issue Date

USPTO Finds Claims Of Two Of Moderna's MRNA Patents Unpatentable: What's Next In The Vaccine Wars?

Unfinished Business In Congress On Drug Patents And Competition

USPTO To Terminate The After Final Consideration Pilot Program 2.0 For Patent Prosecution

USPTO Offers Updated Guidance On Patent Subject Matter Eligibility For AI

Enabling Practitioners: USPTO Issues Guidelines For Assessing Enablement Post-Amgen

Federal Circuit Allows Apple's Fintiv Challenge To Proceed